Cargando…

Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study

BACKGROUND: Use of benzodiazepines (BZD) in patients receiving opioid agonist treatment (OAT) is common and associated with a variety of negative health and social outcomes. This cross-sectional study investigates the impact of BZD use in OAT patients on their quality of life (QoL). METHODS: A conve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyer, Maximilian, Gygli, Ferdinand, Westenberg, Jean N., Schmid, Otto, Strasser, Johannes, Lang, Undine E., Dürsteler, Kenneth M., Vogel, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354905/ https://www.ncbi.nlm.nih.gov/pubmed/37464432 http://dx.doi.org/10.1186/s13722-023-00397-8

Ejemplares similares

Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: a cross-sectional study
por: Meyer, Maximilian, et al.
Publicado: (2023)

Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment
por: Meyer, Maximilian, et al.
Publicado: (2022)

Exploring why patients in heroin-assisted treatment are getting incarcerated—a qualitative study
por: Meyer, Maximilian, et al.
Publicado: (2022)

«One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment
por: Meyer, Maximilian, et al.
Publicado: (2021)

Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016)

Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study
por: Westenberg, Jean N., et al.
Publicado: (2023)

Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice—Identifying Group Differences and Predictors
por: Meyer, Maximilian, et al.
Publicado: (2022)

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment
por: Arnet, Isabelle, et al.
Publicado: (2023)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic–Is an update of legal restrictions warranted?
por: Meyer, Maximilian, et al.
Publicado: (2022)

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy––first long-term case study
por: Allemann, Samuel S., et al.
Publicado: (2017)

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Hazardous use of benzodiazepine receptor agonists in psychiatric clinics in China: electronic prescription database study
por: Xu, Xiaomin, et al.
Publicado: (2022)

Hazardous use of benzodiazepine receptor agonists in psychiatric clinics in China: electronic prescription database study – CORRIGENDUM
por: Xu, Xiaomin, et al.
Publicado: (2022)

Retention in the Austrian opioid agonist treatment system: a national prospective cohort study
por: Busch, Martin, et al.
Publicado: (2021)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

A comparison of opioids and benzodiazepines dispensing in Australia
por: Islam, M. Mofizul, et al.
Publicado: (2019)

‘South Asian cocktail’ - the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour
por: Ojha, Saroj Prasad, et al.
Publicado: (2014)

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization
por: Delaney, Lia D., et al.
Publicado: (2022)

The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster
por: Krausz, R Michael, et al.
Publicado: (2022)

Importance of Opioid Agonist Therapy to Reduce Injection-Related Infections
por: Weaver, Victoria K, et al.
Publicado: (2022)

Breastfeeding on Injectable Opioid Agonist Therapy: A Case Report
por: Patricelli, Charissa J., et al.
Publicado: (2023)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019)

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
por: Chamakalayil, Sunsha, et al.
Publicado: (2021)

Family burden in injecting versus noninjecting opioid users
por: Nebhinani, Naresh, et al.
Publicado: (2013)

Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders – A Narrative Review
por: Köck, Patrick, et al.
Publicado: (2022)

Impact of benzodiazepine consumption reduction on future burden of dementia
por: Jacqmin-Gadda, Hélène, et al.
Publicado: (2020)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Shifting drug markets in North America - a global crisis in the making?
por: Meyer, Maximilian, et al.
Publicado: (2023)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Differences in Benzodiazepine Receptor Agonist Use in Rural and Urban Older Adults
por: Mattos, Meghan K., et al.
Publicado: (2016)

Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
por: Armistead, Lori, et al.
Publicado: (2020)

Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022)

Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study
por: Vogel, Marc, et al.
Publicado: (2023)

Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: Results of an observational trial
por: Wilhelm, Stefan, et al.
Publicado: (2008)

Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy
por: Askaa, Bjarke, et al.
Publicado: (2014)

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study
por: Ekström, Magnus P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v6h0cj4ssms63eckroo5i5dplo